The evaluation of long-term efficacy showed that 85% and 83.4% of super responders vs 54% and 59.2% of non–super responders maintained PASI 100 at years 4 and 5, respectively. IN PRACTICE: ...

The therapy showed an objective response rate of 31.4%, with significant durability in responses, as 31.3% of responders maintained their response at the five-year mark.

Source: Armstrong AW, et al. “Super-response” following treatment with delgocitinib cream 20 mg/g in a subgroup of patients with moderate to severe chronic hand eczema. Presented at: American ...

Rapid responders, which represented 30 percent of the patients undergoing cognitive therapy, were classified as patients who reported adequate relief of pain, adequate relief of bowel symptoms and a ...